- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6869 - Methods for sequencing
Patent holdings for IPC class C12Q 1/6869
Total number of patents in this class: 7087
10-year publication summary
213
|
266
|
571
|
790
|
878
|
995
|
902
|
959
|
933
|
74
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Illumina, Inc. | 3088 |
506 |
Roche Sequencing Solutions, Inc. | 611 |
224 |
Illumina Cambridge Limited | 678 |
201 |
Life Technologies Corporation | 3207 |
157 |
Pacific Biosciences of California, Inc. | 752 |
148 |
Oxford NanoPore Technologies plc | 281 |
142 |
Guardant Health, Inc. | 366 |
117 |
The Regents of the University of California | 19503 |
106 |
President and Fellows of Harvard College | 5911 |
101 |
Natera, Inc. | 294 |
100 |
10X Genomics, Inc. | 1079 |
88 |
Quantum-Si Incorporated | 435 |
87 |
The Board of Trustees of the Leland Stanford Junior University | 6239 |
77 |
Singular Genomics Systems, Inc. | 258 |
66 |
Oxford NanoPore Technologies Limited | 274 |
64 |
F. Hoffmann-La Roche AG | 7938 |
59 |
Ultima Genomics, Inc. | 189 |
59 |
BGI Shenzhen | 472 |
56 |
The Broad Institute, Inc. | 1706 |
55 |
Prognosys Biosciences, Inc. | 96 |
55 |
Other owners | 4619 |